Marie Roskrow
Vorsitzender bei LYTIX BIOPHARMA
Vermögen: - $ am 30.04.2024
Profil
Marie Roskrow is currently the Chairman at Lytix Biopharma AS.
Previously, she held the position of Chief Executive Officer, Executive Director & MD at Patrys Ltd.
from 2012 to 2014.
She also served as Chairman & Chief Executive Officer at Helmholtz Zentrum München and ImevaX GmbH.
Additionally, she was the Executive Chairman at ArcticZymes Technologies ASA from 2023 to 2024.
Dr. Roskrow obtained her undergraduate and doctorate degrees from the University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Marie Roskrow
| Unternehmen | Position | Beginn |
|---|---|---|
| LYTIX BIOPHARMA | Vorsitzender | 18.04.2023 |
Ehemalige bekannte Positionen von Marie Roskrow
| Unternehmen | Position | Ende |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Vorsitzender | 13.05.2024 |
| PATRYS LIMITED | Vorstandsvorsitzender | 29.10.2014 |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Vorstandsvorsitzender | - |
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Vorstandsvorsitzender | - |
Ausbildung von Marie Roskrow
| University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PATRYS LIMITED | Health Technology |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Helmholtz Zentrum München
Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Commercial Services |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
